title: Preventing bowel cancer: an insight for clinicians.
abstract: Worldwide, colorectal cancer causes 610,000 deaths annually with 38,000 new cases diagnosed in the UK and 16,000 deaths each year. The prognosis is directly related to the staging of the cancer at diagnosis, with an overall 5-year survival rate of approximately 50%. However, for localized disease the figure is much higher at 90%, although unfortunately many cancers present at an advanced stage. Importantly, there is the potential to reduce the incidence because most tumours arise from premalignant adenomatous polyps, which if detected and removed interrupts the adenoma-adenocarcinoma sequence. In addition, identifying colorectal cancer at an early stage can impact on the mortality rates for this neoplasm. The current screening options for bowel cancer include analysis of stool for occult blood and endoscopic assessments of the colorectum, including flexible sigmoidoscopy and full colonoscopy. The aim of this review is to present information on the natural history of colorectal cancer, the evaluation of the different screening modalities and the current faecal occult blood screening program within the UK National Health Service, and to discuss how dietary factors and aspirin may affect aetiology.
authors.affiliation: Senior Lecturer in Gastroenterology, Norwich Medical School, University of East Anglia, Norwich, NR4 7TJ, UK.
authors.forename: Andrew R
authors.initials: AR
authors.lastname: Hart
authors.forename: Hugh J
authors.initials: HJ
authors.lastname: Kennedy
references.citation: JAMA. 2005 Dec 14;294(22):2849-57
references.pmid: 16352792
references.citation: Eur J Cancer. 2010 Sep;46(14):2555-62
references.pmid: 20843485
references.citation: Gastroenterology. 1990 Feb;98(2):371-9
references.pmid: 2403953
references.citation: Dis Colon Rectum. 2002 Aug;45(8):1035-40
references.pmid: 12195187
references.citation: Gut. 2001 Apr;48(4):526-35
references.pmid: 11247898
references.citation: Gut. 2010 May;59(5):666-89
references.pmid: 20427401
references.citation: Lancet. 2010 Nov 20;376(9754):1741-50
references.pmid: 20970847
references.citation: JAMA. 2005 Jul 6;294(1):47-55
references.pmid: 15998890
references.citation: Cancer Epidemiol Biomarkers Prev. 2005 Jun;14(6):1552-6
references.pmid: 15941971
references.citation: BMJ. 2010 Jan 21;340:b5500
references.pmid: 20093284
references.citation: J Natl Cancer Inst. 2009 Feb 18;101(4):256-66
references.pmid: 19211452
references.citation: N Engl J Med. 2004 Dec 23;351(26):2704-14
references.pmid: 15616205
references.citation: Gastroenterology. 1987 Nov;93(5):1009-13
references.pmid: 3653628
references.citation: J Neurol Neurosurg Psychiatry. 1991 Dec;54(12):1044-54
references.pmid: 1783914
references.citation: Gut. 1979 Mar;20(3):240-5
references.pmid: 437557
references.citation: Lancet. 1996 Nov 30;348(9040):1467-71
references.pmid: 8942774
references.citation: Cancer Res. 1990 Aug 1;50(15):4724-30
references.pmid: 2369746
references.citation: N Engl J Med. 2008 Sep 18;359(12):1207-17
references.pmid: 18799557
references.citation: Int J Cancer. 2008 Mar 15;122(6):1357-67
references.pmid: 18033685
references.citation: N Engl J Med. 1996 Jan 18;334(3):155-9
references.pmid: 8531970
references.citation: Int J Cancer. 2007 Nov 1;121(9):2065-72
references.pmid: 17640039
references.citation: Ann Surg. 1979 Dec;190(6):679-83
references.pmid: 518167
references.citation: Am J Gastroenterol. 2008 Jun;103(6):1541-9
references.pmid: 18479499
references.citation: Scand J Gastroenterol. 1994 May;29(5):468-73
references.pmid: 8036464
references.citation: Oncogene. 1991 Aug;6(8):1471-6
references.pmid: 1886718
references.citation: J Natl Cancer Inst. 1993 Aug 4;85(15):1220-4
references.pmid: 8331682
references.citation: J Natl Cancer Inst. 2005 Jun 15;97(12):906-16
references.pmid: 15956652
references.citation: Am J Dig Dis. 1977 Sep;22(9):791-7
references.pmid: 900094
references.citation: N Engl J Med. 1993 Apr 1;328(13):901-6
references.pmid: 8446136
references.citation: J Clin Endocrinol Metab. 2001 Jul;86(7):2935-41
references.pmid: 11443146
references.citation: Cancer. 1992 Sep 1;70(5 Suppl):1236-45
references.pmid: 1511370
references.citation: Int J Cancer. 2006 Dec 1;119(11):2657-64
references.pmid: 16991129
references.citation: Gastroenterology. 1997 Jan;112(1):17-23
references.pmid: 8978337
references.citation: J Natl Cancer Inst. 2005 Jul 6;97(13):989-97
references.pmid: 15998952
references.citation: BMJ. 2009 May 29;338:b1846
references.pmid: 19483252
references.citation: Cancer. 1971 Jul;28(1):131-4
references.pmid: 5110619
references.citation: J Natl Cancer Inst. 2002 Dec 4;94(23):1763-72
references.pmid: 12464648
references.citation: Gastroenterology. 1997 Jan;112(1):24-8
references.pmid: 8978338
references.citation: Lancet. 2010 May 8;375(9726):1624-33
references.pmid: 20430429
references.citation: N Engl J Med. 1993 May 13;328(19):1365-71
references.pmid: 8474513
references.citation: Cancer. 1975 Dec;36(6):2251-70
references.pmid: 1203876
references.citation: N Engl J Med. 1992 Mar 5;326(10):658-62
references.pmid: 1736104
references.citation: Br Med J (Clin Res Ed). 1988 Jan 30;296(6618):313-6
references.pmid: 3125882
references.citation: Proc R Soc Med. 1974 Jun;67(6 Pt 1):451-7
references.pmid: 4853754
references.citation: N Engl J Med. 2003 Dec 4;349(23):2191-200
references.pmid: 14657426
references.citation: Gut. 2011 May;60(5):571-607
references.pmid: 21464096
references.citation: Health Technol Assess. 2010 Jun;14(32):1-206
references.pmid: 20594533
references.citation: Aliment Pharmacol Ther. 2004 Oct;20 Suppl 4:24-30
references.pmid: 15352890
references.citation: Lancet. 1996 Nov 30;348(9040):1472-7
references.pmid: 8942775